Royal Bank of Canada’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.97M | Buy |
465,499
+426,121
| +1,082% | +$5.43M | ﹤0.01% | 2279 |
|
|
2025
Q4 | $355K | Sell |
39,378
-425,149
| -92% | -$5.85M | ﹤0.01% | 4414 |
|
|
2025
Q3 | $8.02M | Sell |
464,527
-40,247
| -8% | -$496K | ﹤0.01% | 2301 |
|
|
2025
Q2 | $4.74M | Buy |
504,774
+475,828
| +1,644% | +$3.91M | ﹤0.01% | 2617 |
|
|
2025
Q1 | $206K | Sell |
28,946
-8,698
| -23% | -$87.9K | ﹤0.01% | 4678 |
|
|
2024
Q4 | $439K | Sell |
37,644
-76,490
| -67% | -$1.19M | ﹤0.01% | 4176 |
|
|
2024
Q3 | $2.35M | Sell |
114,134
-582
| -0.5% | -$13.4K | ﹤0.01% | 2878 |
|
|
2024
Q2 | $2.57M | Sell |
114,716
-384
| -0.3% | -$9.14K | ﹤0.01% | 2715 |
|
|
2024
Q1 | $3.17M | Sell |
115,100
-38,512
| -25% | -$1.07M | ﹤0.01% | 2555 |
|
|
2023
Q4 | $4.68M | Buy |
153,612
+70,056
| +84% | +$2.01M | ﹤0.01% | 2300 |
|
|
2023
Q3 | $2.64M | Buy |
83,556
+50,344
| +152% | +$1.95M | ﹤0.01% | 2619 |
|
|
2023
Q2 | $1.35M | Buy |
33,212
+5,346
| +19% | +$217K | ﹤0.01% | 3142 |
|
|
2023
Q1 | $1.04M | Sell |
27,866
-8,356
| -23% | -$328K | ﹤0.01% | 3310 |
|
|
2022
Q4 | $1.26M | Buy |
36,222
+17,150
| +90% | +$815K | ﹤0.01% | 3301 |
|
|
2022
Q3 | $1.07M | Sell |
19,072
-1,204
| -6% | -$74.7K | ﹤0.01% | 3397 |
|
|
2022
Q2 | $1.05M | Sell |
20,276
-10,431
| -34% | -$530K | ﹤0.01% | 3464 |
|
|
2022
Q1 | $2.23M | Sell |
30,707
-1,206
| -4% | -$102K | ﹤0.01% | 2960 |
|
|
2021
Q4 | $3.77M | Buy |
31,913
+8,172
| +34% | +$1.02M | ﹤0.01% | 2588 |
|
|
2021
Q3 | $3.18M | Buy |
23,741
+1,178
| +5% | +$178K | ﹤0.01% | 2682 |
|
|
2021
Q2 | $3.65M | Sell |
22,563
-1,505
| -6% | -$117K | ﹤0.01% | 2531 |
|
|
2021
Q1 | $1.93M | Sell |
24,068
-102,112
| -81% | -$6.85M | ﹤0.01% | 3038 |
|
|
2020
Q4 | $6.86M | Buy |
126,180
+683
| +0.5% | +$24.8K | ﹤0.01% | 1974 |
|
|
2020
Q3 | $2.5M | Sell |
125,497
-2,121
| -2% | -$44.2K | ﹤0.01% | 2505 |
|
|
2020
Q2 | $2.68M | Buy |
127,618
+8,580
| +7% | +$146K | ﹤0.01% | 2391 |
|
|
2020
Q1 | $1.46M | Sell |
119,038
-4,815
| -4% | -$64.9K | ﹤0.01% | 2725 |
|
|
2019
Q4 | $1.82M | Sell |
123,853
-7,992
| -6% | -$111K | ﹤0.01% | 2953 |
|
|
2019
Q3 | $1.76M | Sell |
131,845
-1,878
| -1% | -$29.9K | ﹤0.01% | 2856 |
|
|
2019
Q2 | $2.19M | Buy |
133,723
+98,339
| +278% | +$1.55M | ﹤0.01% | 2681 |
|
|
2019
Q1 | $604K | Buy |
35,384
+2,950
| +9% | +$44K | ﹤0.01% | 3603 |
|
|
2018
Q4 | $442K | Sell |
32,434
-6,031
| -16% | -$112K | ﹤0.01% | 3807 |
|
|
2018
Q3 | $1.1M | Sell |
38,465
-275
| -0.7% | -$8K | ﹤0.01% | 3282 |
|
|
2018
Q2 | $1.06M | Buy |
38,740
+8,420
| +28% | +$204K | ﹤0.01% | 3189 |
|
|
2018
Q1 | $640K | Buy |
30,320
+25,443
| +522% | +$626K | ﹤0.01% | 3522 |
|
|
2017
Q4 | $93K | Sell |
4,877
-1,526
| -24% | -$35.2K | ﹤0.01% | 4855 |
|
|
2017
Q3 | $159K | Buy |
6,403
+744
| +13% | +$14K | ﹤0.01% | 4676 |
|
|
2017
Q2 | $91K | Buy |
5,659
+1,357
| +32% | +$19K | ﹤0.01% | 4819 |
|
|
2017
Q1 | $61K | Sell |
4,302
-4,613
| -52% | -$61.9K | ﹤0.01% | 5045 |
|
|
2016
Q4 | $117K | Buy |
8,915
+881
| +11% | +$13.2K | ﹤0.01% | 4792 |
|
|
2016
Q3 | $136K | Buy |
+8,034
| New | +$156K | ﹤0.01% | 4660 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
